nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Methotrexate—esophageal cancer	0.646	0.827	CbGbCtD
Foscarnet—SLC22A6—Methotrexate—esophageal cancer	0.135	0.173	CbGbCtD
Foscarnet—Nephrotoxicity—Cisplatin—esophageal cancer	0.0053	0.0242	CcSEcCtD
Foscarnet—Cachexia—Capecitabine—esophageal cancer	0.00435	0.0199	CcSEcCtD
Foscarnet—Sinus tachycardia—Capecitabine—esophageal cancer	0.00308	0.0141	CcSEcCtD
Foscarnet—Nephropathy toxic—Cisplatin—esophageal cancer	0.00293	0.0134	CcSEcCtD
Foscarnet—Hypophosphataemia—Cisplatin—esophageal cancer	0.0029	0.0133	CcSEcCtD
Foscarnet—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.0029	0.0133	CcSEcCtD
Foscarnet—Serum creatinine increased—Cisplatin—esophageal cancer	0.00274	0.0125	CcSEcCtD
Foscarnet—Pneumothorax—Capecitabine—esophageal cancer	0.0025	0.0114	CcSEcCtD
Foscarnet—Dementia—Methotrexate—esophageal cancer	0.00225	0.0103	CcSEcCtD
Foscarnet—Abscess—Cisplatin—esophageal cancer	0.00213	0.00973	CcSEcCtD
Foscarnet—Infection—Carboplatin—esophageal cancer	0.00204	0.00931	CcSEcCtD
Foscarnet—Serum creatinine increased—Capecitabine—esophageal cancer	0.00202	0.00923	CcSEcCtD
Foscarnet—Bacterial infection—Methotrexate—esophageal cancer	0.002	0.00915	CcSEcCtD
Foscarnet—Ulcerative stomatitis—Methotrexate—esophageal cancer	0.002	0.00915	CcSEcCtD
Foscarnet—Lung infiltration—Methotrexate—esophageal cancer	0.00197	0.00901	CcSEcCtD
Foscarnet—Hypomagnesaemia—Capecitabine—esophageal cancer	0.00196	0.00894	CcSEcCtD
Foscarnet—Aphasia—Capecitabine—esophageal cancer	0.00192	0.00875	CcSEcCtD
Foscarnet—Thrombosis—Capecitabine—esophageal cancer	0.00176	0.00802	CcSEcCtD
Foscarnet—Pain—Carboplatin—esophageal cancer	0.00175	0.00801	CcSEcCtD
Foscarnet—Haemoptysis—Capecitabine—esophageal cancer	0.00168	0.00767	CcSEcCtD
Foscarnet—Rash erythematous—Capecitabine—esophageal cancer	0.00162	0.00741	CcSEcCtD
Foscarnet—Body temperature increased—Carboplatin—esophageal cancer	0.00162	0.0074	CcSEcCtD
Foscarnet—Fungal infection—Capecitabine—esophageal cancer	0.00161	0.00735	CcSEcCtD
Foscarnet—Skin ulcer—Capecitabine—esophageal cancer	0.0016	0.00729	CcSEcCtD
Foscarnet—Neuropathy—Cisplatin—esophageal cancer	0.00158	0.00723	CcSEcCtD
Foscarnet—Rigors—Capecitabine—esophageal cancer	0.00152	0.00695	CcSEcCtD
Foscarnet—Injection site pain—Capecitabine—esophageal cancer	0.00152	0.00695	CcSEcCtD
Foscarnet—Aphasia—Methotrexate—esophageal cancer	0.00143	0.00652	CcSEcCtD
Foscarnet—Polyuria—Cisplatin—esophageal cancer	0.00139	0.00637	CcSEcCtD
Foscarnet—Rectal haemorrhage—Capecitabine—esophageal cancer	0.00138	0.00628	CcSEcCtD
Foscarnet—Skin discolouration—Capecitabine—esophageal cancer	0.00138	0.00628	CcSEcCtD
Foscarnet—Hypocalcaemia—Capecitabine—esophageal cancer	0.00136	0.0062	CcSEcCtD
Foscarnet—Nocturia—Capecitabine—esophageal cancer	0.00134	0.00612	CcSEcCtD
Foscarnet—Renal failure acute—Cisplatin—esophageal cancer	0.00133	0.00605	CcSEcCtD
Foscarnet—Amnesia—Cisplatin—esophageal cancer	0.0013	0.00595	CcSEcCtD
Foscarnet—Coordination abnormal—Capecitabine—esophageal cancer	0.00127	0.00578	CcSEcCtD
Foscarnet—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00124	0.00568	CcSEcCtD
Foscarnet—Stupor—Methotrexate—esophageal cancer	0.00124	0.00566	CcSEcCtD
Foscarnet—Hyponatraemia—Cisplatin—esophageal cancer	0.00123	0.00561	CcSEcCtD
Foscarnet—Melaena—Capecitabine—esophageal cancer	0.00121	0.00554	CcSEcCtD
Foscarnet—Influenza like illness—Capecitabine—esophageal cancer	0.00121	0.00551	CcSEcCtD
Foscarnet—Depressed level of consciousness—Capecitabine—esophageal cancer	0.0012	0.00548	CcSEcCtD
Foscarnet—Fungal infection—Methotrexate—esophageal cancer	0.0012	0.00547	CcSEcCtD
Foscarnet—Skin ulcer—Methotrexate—esophageal cancer	0.00119	0.00543	CcSEcCtD
Foscarnet—Candida infection—Capecitabine—esophageal cancer	0.00119	0.00542	CcSEcCtD
Foscarnet—Face oedema—Cisplatin—esophageal cancer	0.00118	0.0054	CcSEcCtD
Foscarnet—Abscess—Methotrexate—esophageal cancer	0.00117	0.00534	CcSEcCtD
Foscarnet—Neuropathy—Capecitabine—esophageal cancer	0.00117	0.00533	CcSEcCtD
Foscarnet—Blood creatinine increased—Cisplatin—esophageal cancer	0.00115	0.00524	CcSEcCtD
Foscarnet—Dehydration—Cisplatin—esophageal cancer	0.00114	0.0052	CcSEcCtD
Foscarnet—Mouth ulceration—Capecitabine—esophageal cancer	0.00112	0.00513	CcSEcCtD
Foscarnet—Neoplasm—Capecitabine—esophageal cancer	0.00112	0.00513	CcSEcCtD
Foscarnet—Urine output increased—Capecitabine—esophageal cancer	0.00112	0.00513	CcSEcCtD
Foscarnet—Hypokalaemia—Cisplatin—esophageal cancer	0.00111	0.00509	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.0011	0.00503	CcSEcCtD
Foscarnet—Sepsis—Capecitabine—esophageal cancer	0.00108	0.00493	CcSEcCtD
Foscarnet—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00104	0.00474	CcSEcCtD
Foscarnet—Pancreatitis—Cisplatin—esophageal cancer	0.00104	0.00474	CcSEcCtD
Foscarnet—Sweating increased—Cisplatin—esophageal cancer	0.00103	0.00471	CcSEcCtD
Foscarnet—Polyuria—Capecitabine—esophageal cancer	0.00103	0.00469	CcSEcCtD
Foscarnet—Skin discolouration—Methotrexate—esophageal cancer	0.00102	0.00468	CcSEcCtD
Foscarnet—Pancytopenia—Cisplatin—esophageal cancer	0.001	0.00459	CcSEcCtD
Foscarnet—Eye pain—Capecitabine—esophageal cancer	0.000999	0.00456	CcSEcCtD
Foscarnet—Renal failure acute—Capecitabine—esophageal cancer	0.000977	0.00446	CcSEcCtD
Foscarnet—Amnesia—Capecitabine—esophageal cancer	0.00096	0.00439	CcSEcCtD
Foscarnet—Renal impairment—Capecitabine—esophageal cancer	0.000948	0.00433	CcSEcCtD
Foscarnet—Thirst—Capecitabine—esophageal cancer	0.000948	0.00433	CcSEcCtD
Foscarnet—Dermatitis bullous—Capecitabine—esophageal cancer	0.000944	0.00431	CcSEcCtD
Foscarnet—Respiratory failure—Methotrexate—esophageal cancer	0.000942	0.0043	CcSEcCtD
Foscarnet—Renal failure—Cisplatin—esophageal cancer	0.000927	0.00423	CcSEcCtD
Foscarnet—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000924	0.00422	CcSEcCtD
Foscarnet—Conjunctivitis—Cisplatin—esophageal cancer	0.000917	0.00419	CcSEcCtD
Foscarnet—Hyponatraemia—Capecitabine—esophageal cancer	0.000906	0.00414	CcSEcCtD
Foscarnet—Melaena—Methotrexate—esophageal cancer	0.000903	0.00413	CcSEcCtD
Foscarnet—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000893	0.00408	CcSEcCtD
Foscarnet—Face oedema—Capecitabine—esophageal cancer	0.000871	0.00398	CcSEcCtD
Foscarnet—Cardiac arrest—Capecitabine—esophageal cancer	0.000858	0.00392	CcSEcCtD
Foscarnet—Urinary retention—Capecitabine—esophageal cancer	0.000858	0.00392	CcSEcCtD
Foscarnet—Ataxia—Capecitabine—esophageal cancer	0.000848	0.00387	CcSEcCtD
Foscarnet—Coma—Methotrexate—esophageal cancer	0.000845	0.00386	CcSEcCtD
Foscarnet—Blood creatinine increased—Capecitabine—esophageal cancer	0.000845	0.00386	CcSEcCtD
Foscarnet—Dehydration—Capecitabine—esophageal cancer	0.000839	0.00383	CcSEcCtD
Foscarnet—Mouth ulceration—Methotrexate—esophageal cancer	0.000836	0.00382	CcSEcCtD
Foscarnet—Neoplasm—Methotrexate—esophageal cancer	0.000836	0.00382	CcSEcCtD
Foscarnet—Urine output increased—Methotrexate—esophageal cancer	0.000836	0.00382	CcSEcCtD
Foscarnet—Urethral disorder—Cisplatin—esophageal cancer	0.00083	0.00379	CcSEcCtD
Foscarnet—Hypokalaemia—Capecitabine—esophageal cancer	0.000821	0.00375	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000812	0.00371	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000812	0.00371	CcSEcCtD
Foscarnet—Sepsis—Methotrexate—esophageal cancer	0.000803	0.00367	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000795	0.00363	CcSEcCtD
Foscarnet—Muscular weakness—Capecitabine—esophageal cancer	0.000795	0.00363	CcSEcCtD
Foscarnet—Eye disorder—Cisplatin—esophageal cancer	0.000791	0.00361	CcSEcCtD
Foscarnet—Lymphadenopathy—Methotrexate—esophageal cancer	0.000787	0.0036	CcSEcCtD
Foscarnet—Flushing—Cisplatin—esophageal cancer	0.000786	0.00359	CcSEcCtD
Foscarnet—Dysphagia—Capecitabine—esophageal cancer	0.00078	0.00356	CcSEcCtD
Foscarnet—Bronchospasm—Capecitabine—esophageal cancer	0.000767	0.0035	CcSEcCtD
Foscarnet—Polyuria—Methotrexate—esophageal cancer	0.000765	0.00349	CcSEcCtD
Foscarnet—Sweating increased—Capecitabine—esophageal cancer	0.000759	0.00347	CcSEcCtD
Foscarnet—Pancytopenia—Capecitabine—esophageal cancer	0.00074	0.00338	CcSEcCtD
Foscarnet—Dysuria—Capecitabine—esophageal cancer	0.000729	0.00333	CcSEcCtD
Foscarnet—Neutropenia—Capecitabine—esophageal cancer	0.000729	0.00333	CcSEcCtD
Foscarnet—Renal failure acute—Methotrexate—esophageal cancer	0.000727	0.00332	CcSEcCtD
Foscarnet—Flatulence—Cisplatin—esophageal cancer	0.000726	0.00332	CcSEcCtD
Foscarnet—Muscle spasms—Cisplatin—esophageal cancer	0.000708	0.00324	CcSEcCtD
Foscarnet—Weight decreased—Capecitabine—esophageal cancer	0.000705	0.00322	CcSEcCtD
Foscarnet—Tremor—Cisplatin—esophageal cancer	0.00069	0.00315	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000689	0.00315	CcSEcCtD
Foscarnet—Ill-defined disorder—Cisplatin—esophageal cancer	0.000684	0.00312	CcSEcCtD
Foscarnet—Renal failure—Capecitabine—esophageal cancer	0.000683	0.00312	CcSEcCtD
Foscarnet—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000681	0.00311	CcSEcCtD
Foscarnet—Anaemia—Cisplatin—esophageal cancer	0.000681	0.00311	CcSEcCtD
Foscarnet—Conjunctivitis—Capecitabine—esophageal cancer	0.000676	0.00309	CcSEcCtD
Foscarnet—Urinary tract infection—Capecitabine—esophageal cancer	0.000676	0.00309	CcSEcCtD
Foscarnet—Malaise—Cisplatin—esophageal cancer	0.000664	0.00304	CcSEcCtD
Foscarnet—Haematuria—Capecitabine—esophageal cancer	0.000663	0.00303	CcSEcCtD
Foscarnet—Leukopenia—Cisplatin—esophageal cancer	0.00066	0.00301	CcSEcCtD
Foscarnet—Agranulocytosis—Capecitabine—esophageal cancer	0.000649	0.00296	CcSEcCtD
Foscarnet—Convulsion—Cisplatin—esophageal cancer	0.000638	0.00292	CcSEcCtD
Foscarnet—Ataxia—Methotrexate—esophageal cancer	0.000631	0.00288	CcSEcCtD
Foscarnet—Myalgia—Cisplatin—esophageal cancer	0.000627	0.00287	CcSEcCtD
Foscarnet—Rhinitis—Capecitabine—esophageal cancer	0.000626	0.00286	CcSEcCtD
Foscarnet—Anxiety—Cisplatin—esophageal cancer	0.000625	0.00286	CcSEcCtD
Foscarnet—Hypoaesthesia—Capecitabine—esophageal cancer	0.000621	0.00284	CcSEcCtD
Foscarnet—Discomfort—Cisplatin—esophageal cancer	0.00062	0.00283	CcSEcCtD
Foscarnet—Pharyngitis—Capecitabine—esophageal cancer	0.000619	0.00283	CcSEcCtD
Foscarnet—Urethral disorder—Capecitabine—esophageal cancer	0.000612	0.00279	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000605	0.00276	CcSEcCtD
Foscarnet—Oedema—Cisplatin—esophageal cancer	0.000601	0.00275	CcSEcCtD
Foscarnet—Infection—Cisplatin—esophageal cancer	0.000597	0.00273	CcSEcCtD
Foscarnet—Erythema multiforme—Capecitabine—esophageal cancer	0.00059	0.0027	CcSEcCtD
Foscarnet—Thrombocytopenia—Cisplatin—esophageal cancer	0.000589	0.00269	CcSEcCtD
Foscarnet—Eye disorder—Capecitabine—esophageal cancer	0.000583	0.00266	CcSEcCtD
Foscarnet—Hyperhidrosis—Cisplatin—esophageal cancer	0.000581	0.00266	CcSEcCtD
Foscarnet—Flushing—Capecitabine—esophageal cancer	0.000579	0.00265	CcSEcCtD
Foscarnet—Anorexia—Cisplatin—esophageal cancer	0.000573	0.00262	CcSEcCtD
Foscarnet—Pancreatitis—Methotrexate—esophageal cancer	0.000569	0.0026	CcSEcCtD
Foscarnet—Hypotension—Cisplatin—esophageal cancer	0.000562	0.00257	CcSEcCtD
Foscarnet—Chills—Capecitabine—esophageal cancer	0.00056	0.00256	CcSEcCtD
Foscarnet—Pancytopenia—Methotrexate—esophageal cancer	0.000551	0.00252	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000548	0.0025	CcSEcCtD
Foscarnet—Neutropenia—Methotrexate—esophageal cancer	0.000543	0.00248	CcSEcCtD
Foscarnet—Dysuria—Methotrexate—esophageal cancer	0.000543	0.00248	CcSEcCtD
Foscarnet—Paraesthesia—Cisplatin—esophageal cancer	0.00054	0.00247	CcSEcCtD
Foscarnet—Dyspnoea—Cisplatin—esophageal cancer	0.000536	0.00245	CcSEcCtD
Foscarnet—Flatulence—Capecitabine—esophageal cancer	0.000535	0.00245	CcSEcCtD
Foscarnet—Back pain—Capecitabine—esophageal cancer	0.000525	0.0024	CcSEcCtD
Foscarnet—Decreased appetite—Cisplatin—esophageal cancer	0.000523	0.00239	CcSEcCtD
Foscarnet—Muscle spasms—Capecitabine—esophageal cancer	0.000522	0.00239	CcSEcCtD
Foscarnet—Pain—Cisplatin—esophageal cancer	0.000514	0.00235	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000513	0.00234	CcSEcCtD
Foscarnet—Tremor—Capecitabine—esophageal cancer	0.000509	0.00232	CcSEcCtD
Foscarnet—Renal failure—Methotrexate—esophageal cancer	0.000509	0.00232	CcSEcCtD
Foscarnet—Ill-defined disorder—Capecitabine—esophageal cancer	0.000504	0.0023	CcSEcCtD
Foscarnet—Conjunctivitis—Methotrexate—esophageal cancer	0.000503	0.0023	CcSEcCtD
Foscarnet—Anaemia—Capecitabine—esophageal cancer	0.000502	0.00229	CcSEcCtD
Foscarnet—Feeling abnormal—Cisplatin—esophageal cancer	0.000496	0.00226	CcSEcCtD
Foscarnet—Haematuria—Methotrexate—esophageal cancer	0.000493	0.00225	CcSEcCtD
Foscarnet—Malaise—Capecitabine—esophageal cancer	0.00049	0.00224	CcSEcCtD
Foscarnet—Leukopenia—Capecitabine—esophageal cancer	0.000486	0.00222	CcSEcCtD
Foscarnet—Agranulocytosis—Methotrexate—esophageal cancer	0.000483	0.00221	CcSEcCtD
Foscarnet—Palpitations—Capecitabine—esophageal cancer	0.00048	0.00219	CcSEcCtD
Foscarnet—Body temperature increased—Cisplatin—esophageal cancer	0.000475	0.00217	CcSEcCtD
Foscarnet—Cough—Capecitabine—esophageal cancer	0.000474	0.00217	CcSEcCtD
Foscarnet—Hypertension—Capecitabine—esophageal cancer	0.000469	0.00214	CcSEcCtD
Foscarnet—Arthralgia—Capecitabine—esophageal cancer	0.000462	0.00211	CcSEcCtD
Foscarnet—Chest pain—Capecitabine—esophageal cancer	0.000462	0.00211	CcSEcCtD
Foscarnet—Myalgia—Capecitabine—esophageal cancer	0.000462	0.00211	CcSEcCtD
Foscarnet—Pharyngitis—Methotrexate—esophageal cancer	0.000461	0.00211	CcSEcCtD
Foscarnet—Anxiety—Capecitabine—esophageal cancer	0.000461	0.00211	CcSEcCtD
Foscarnet—Discomfort—Capecitabine—esophageal cancer	0.000457	0.00209	CcSEcCtD
Foscarnet—Urethral disorder—Methotrexate—esophageal cancer	0.000455	0.00208	CcSEcCtD
Foscarnet—Dry mouth—Capecitabine—esophageal cancer	0.000452	0.00207	CcSEcCtD
Foscarnet—Confusional state—Capecitabine—esophageal cancer	0.000447	0.00204	CcSEcCtD
Foscarnet—Oedema—Capecitabine—esophageal cancer	0.000443	0.00203	CcSEcCtD
Foscarnet—Infection—Capecitabine—esophageal cancer	0.00044	0.00201	CcSEcCtD
Foscarnet—Erythema multiforme—Methotrexate—esophageal cancer	0.000439	0.00201	CcSEcCtD
Foscarnet—Eye disorder—Methotrexate—esophageal cancer	0.000434	0.00198	CcSEcCtD
Foscarnet—Thrombocytopenia—Capecitabine—esophageal cancer	0.000434	0.00198	CcSEcCtD
Foscarnet—Asthenia—Cisplatin—esophageal cancer	0.000431	0.00197	CcSEcCtD
Foscarnet—Hyperhidrosis—Capecitabine—esophageal cancer	0.000429	0.00196	CcSEcCtD
Foscarnet—Anorexia—Capecitabine—esophageal cancer	0.000423	0.00193	CcSEcCtD
Foscarnet—Chills—Methotrexate—esophageal cancer	0.000417	0.0019	CcSEcCtD
Foscarnet—Hypotension—Capecitabine—esophageal cancer	0.000414	0.00189	CcSEcCtD
Foscarnet—Diarrhoea—Cisplatin—esophageal cancer	0.000411	0.00188	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000404	0.00185	CcSEcCtD
Foscarnet—Insomnia—Capecitabine—esophageal cancer	0.000401	0.00183	CcSEcCtD
Foscarnet—Paraesthesia—Capecitabine—esophageal cancer	0.000398	0.00182	CcSEcCtD
Foscarnet—Dyspnoea—Capecitabine—esophageal cancer	0.000395	0.00181	CcSEcCtD
Foscarnet—Back pain—Methotrexate—esophageal cancer	0.000391	0.00179	CcSEcCtD
Foscarnet—Dyspepsia—Capecitabine—esophageal cancer	0.00039	0.00178	CcSEcCtD
Foscarnet—Decreased appetite—Capecitabine—esophageal cancer	0.000385	0.00176	CcSEcCtD
Foscarnet—Vomiting—Cisplatin—esophageal cancer	0.000382	0.00175	CcSEcCtD
Foscarnet—Fatigue—Capecitabine—esophageal cancer	0.000382	0.00175	CcSEcCtD
Foscarnet—Rash—Cisplatin—esophageal cancer	0.000379	0.00173	CcSEcCtD
Foscarnet—Pain—Capecitabine—esophageal cancer	0.000379	0.00173	CcSEcCtD
Foscarnet—Constipation—Capecitabine—esophageal cancer	0.000379	0.00173	CcSEcCtD
Foscarnet—Dermatitis—Cisplatin—esophageal cancer	0.000379	0.00173	CcSEcCtD
Foscarnet—Ill-defined disorder—Methotrexate—esophageal cancer	0.000375	0.00171	CcSEcCtD
Foscarnet—Anaemia—Methotrexate—esophageal cancer	0.000374	0.00171	CcSEcCtD
Foscarnet—Feeling abnormal—Capecitabine—esophageal cancer	0.000365	0.00167	CcSEcCtD
Foscarnet—Malaise—Methotrexate—esophageal cancer	0.000365	0.00167	CcSEcCtD
Foscarnet—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000362	0.00166	CcSEcCtD
Foscarnet—Leukopenia—Methotrexate—esophageal cancer	0.000362	0.00165	CcSEcCtD
Foscarnet—Nausea—Cisplatin—esophageal cancer	0.000357	0.00163	CcSEcCtD
Foscarnet—Cough—Methotrexate—esophageal cancer	0.000353	0.00161	CcSEcCtD
Foscarnet—Abdominal pain—Capecitabine—esophageal cancer	0.00035	0.0016	CcSEcCtD
Foscarnet—Body temperature increased—Capecitabine—esophageal cancer	0.00035	0.0016	CcSEcCtD
Foscarnet—Convulsion—Methotrexate—esophageal cancer	0.00035	0.0016	CcSEcCtD
Foscarnet—Arthralgia—Methotrexate—esophageal cancer	0.000344	0.00157	CcSEcCtD
Foscarnet—Chest pain—Methotrexate—esophageal cancer	0.000344	0.00157	CcSEcCtD
Foscarnet—Myalgia—Methotrexate—esophageal cancer	0.000344	0.00157	CcSEcCtD
Foscarnet—Discomfort—Methotrexate—esophageal cancer	0.00034	0.00155	CcSEcCtD
Foscarnet—Confusional state—Methotrexate—esophageal cancer	0.000333	0.00152	CcSEcCtD
Foscarnet—Infection—Methotrexate—esophageal cancer	0.000328	0.0015	CcSEcCtD
Foscarnet—Thrombocytopenia—Methotrexate—esophageal cancer	0.000323	0.00148	CcSEcCtD
Foscarnet—Hyperhidrosis—Methotrexate—esophageal cancer	0.000319	0.00146	CcSEcCtD
Foscarnet—Asthenia—Capecitabine—esophageal cancer	0.000318	0.00145	CcSEcCtD
Foscarnet—Anorexia—Methotrexate—esophageal cancer	0.000315	0.00144	CcSEcCtD
Foscarnet—Pruritus—Capecitabine—esophageal cancer	0.000314	0.00143	CcSEcCtD
Foscarnet—Hypotension—Methotrexate—esophageal cancer	0.000308	0.00141	CcSEcCtD
Foscarnet—Diarrhoea—Capecitabine—esophageal cancer	0.000303	0.00139	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000301	0.00137	CcSEcCtD
Foscarnet—Insomnia—Methotrexate—esophageal cancer	0.000298	0.00136	CcSEcCtD
Foscarnet—Paraesthesia—Methotrexate—esophageal cancer	0.000296	0.00135	CcSEcCtD
Foscarnet—Dyspnoea—Methotrexate—esophageal cancer	0.000294	0.00134	CcSEcCtD
Foscarnet—Somnolence—Methotrexate—esophageal cancer	0.000293	0.00134	CcSEcCtD
Foscarnet—Dizziness—Capecitabine—esophageal cancer	0.000293	0.00134	CcSEcCtD
Foscarnet—Dyspepsia—Methotrexate—esophageal cancer	0.00029	0.00133	CcSEcCtD
Foscarnet—Decreased appetite—Methotrexate—esophageal cancer	0.000287	0.00131	CcSEcCtD
Foscarnet—Fatigue—Methotrexate—esophageal cancer	0.000285	0.0013	CcSEcCtD
Foscarnet—Pain—Methotrexate—esophageal cancer	0.000282	0.00129	CcSEcCtD
Foscarnet—Vomiting—Capecitabine—esophageal cancer	0.000282	0.00129	CcSEcCtD
Foscarnet—Rash—Capecitabine—esophageal cancer	0.000279	0.00128	CcSEcCtD
Foscarnet—Dermatitis—Capecitabine—esophageal cancer	0.000279	0.00128	CcSEcCtD
Foscarnet—Headache—Capecitabine—esophageal cancer	0.000278	0.00127	CcSEcCtD
Foscarnet—Feeling abnormal—Methotrexate—esophageal cancer	0.000272	0.00124	CcSEcCtD
Foscarnet—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00027	0.00123	CcSEcCtD
Foscarnet—Nausea—Capecitabine—esophageal cancer	0.000263	0.0012	CcSEcCtD
Foscarnet—Abdominal pain—Methotrexate—esophageal cancer	0.000261	0.00119	CcSEcCtD
Foscarnet—Body temperature increased—Methotrexate—esophageal cancer	0.000261	0.00119	CcSEcCtD
Foscarnet—Asthenia—Methotrexate—esophageal cancer	0.000237	0.00108	CcSEcCtD
Foscarnet—Pruritus—Methotrexate—esophageal cancer	0.000233	0.00107	CcSEcCtD
Foscarnet—Diarrhoea—Methotrexate—esophageal cancer	0.000226	0.00103	CcSEcCtD
Foscarnet—Dizziness—Methotrexate—esophageal cancer	0.000218	0.000997	CcSEcCtD
Foscarnet—Vomiting—Methotrexate—esophageal cancer	0.00021	0.000959	CcSEcCtD
Foscarnet—Rash—Methotrexate—esophageal cancer	0.000208	0.000951	CcSEcCtD
Foscarnet—Dermatitis—Methotrexate—esophageal cancer	0.000208	0.00095	CcSEcCtD
Foscarnet—Headache—Methotrexate—esophageal cancer	0.000207	0.000944	CcSEcCtD
Foscarnet—Nausea—Methotrexate—esophageal cancer	0.000196	0.000896	CcSEcCtD
